These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35069142)

  • 1. Synaptosomal-Associated Protein 25 Gene Polymorphisms Affect Treatment Efficiency of Methylphenidate in Children With Attention-Deficit Hyperactivity Disorder: An fNIRS Study.
    Li J; Yan WJ; Wu Y; Tian XX; Zhang YW
    Front Behav Neurosci; 2021; 15():793643. PubMed ID: 35069142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association among SNAP-25 gene DdeI and MnlI polymorphisms and hemodynamic changes during methylphenidate use: a functional near-infrared spectroscopy study.
    Öner Ö; Akın A; Herken H; Erdal ME; Çiftçi K; Ay ME; Bicer D; Öncü B; Bozkurt OH; Münir K; Yazgan Y
    J Atten Disord; 2011 Nov; 15(8):628-37. PubMed ID: 20679152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dorsolateral prefrontal cortex dysfunction caused by a go/no-go task in children with attention-deficit hyperactivity disorder: A functional near-infrared spectroscopy study.
    Wu T; Liu X; Cheng F; Wang S; Li C; Zhou D; Zhang W
    Front Neurosci; 2023; 17():1145485. PubMed ID: 37056303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the SNAP-25 gene and the effects of methylphenidate on the anterior cingulate cortex of patients with adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
    Ünal GA; İnci Kenar AN; Tepeli E; Kıroğlu Y; Herken H
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2443-9. PubMed ID: 27338073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS.
    Monden Y; Dan H; Nagashima M; Dan I; Kyutoku Y; Okamoto M; Yamagata T; Momoi MY; Watanabe E
    Clin Neurophysiol; 2012 Jun; 123(6):1147-57. PubMed ID: 22088661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Virtual Reality Working Memory Task and Functional Near-Infrared Spectroscopy to Assess Brain Hemodynamic Responses to Methylphenidate in ADHD Children.
    Jang S; Choi J; Oh J; Yeom J; Hong N; Lee N; Kwon JH; Hong J; Kim JJ; Kim E
    Front Psychiatry; 2020; 11():564618. PubMed ID: 33551860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Prefrontal Cortex Activation in Children with Attention-Deficit/Hyperactivity Disorder during Go/No-Go Task: A Functional Near-Infrared Spectroscopy Study.
    Miao S; Han J; Gu Y; Wang X; Song W; Li D; Liu Z; Yang J; Li X
    Front Neurosci; 2017; 11():367. PubMed ID: 28701914
    [No Abstract]   [Full Text] [Related]  

  • 8. Right prefrontal activation as a neuro-functional biomarker for monitoring acute effects of methylphenidate in ADHD children: An fNIRS study.
    Monden Y; Dan H; Nagashima M; Dan I; Tsuzuki D; Kyutoku Y; Gunji Y; Yamagata T; Watanabe E; Momoi MY
    Neuroimage Clin; 2012; 1(1):131-40. PubMed ID: 24179746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.
    Cho SC; Kim BN; Cummins TD; Kim JW; Bellgrove MA
    J Psychopharmacol; 2012 Mar; 26(3):380-9. PubMed ID: 21628343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of SNAP-25 Gene Ddel and Mnll Polymorphisms with Adult Attention Deficit Hyperactivity Disorder.
    Herken H; Erdal ME; Kenar AN; Unal GA; Cakaloz B; Ay ME; Yücel E; Edgünlü T; Sengül C
    Psychiatry Investig; 2014 Oct; 11(4):476-80. PubMed ID: 25395980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Methylphenidate-Evoked Response Measured Using Functional Near-Infrared Spectroscopy During Go/No-Go Task as a Supporting Differential Diagnostic Tool Between Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Comorbid Children.
    Sutoko S; Monden Y; Tokuda T; Ikeda T; Nagashima M; Kiguchi M; Maki A; Yamagata T; Dan I
    Front Hum Neurosci; 2019; 13():7. PubMed ID: 30800062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy.
    Nakanishi Y; Ota T; Iida J; Yamamuro K; Kishimoto N; Okazaki K; Kishimoto T
    Child Adolesc Psychiatry Ment Health; 2017; 11():26. PubMed ID: 28507595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methylphenidate in children with attention deficit hyperactivity disorder: a near-infrared spectroscopy study with CANTAB®.
    Matsuura N; Ishitobi M; Arai S; Kawamura K; Asano M; Inohara K; Fujioka T; Narimoto T; Wada Y; Hiratani M; Kosaka H
    Child Adolesc Psychiatry Ment Health; 2014; 8(1):273. PubMed ID: 25606052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate.
    Chou WJ; Chen SJ; Chen YS; Liang HY; Lin CC; Tang CS; Huang YS; Yeh CB; Chou MC; Lin DY; Hou PH; Wu YY; Liu HJ; Huang YF; Hwang KL; Chan CH; Pan CH; Chang HL; Huang CF; Hsu JW
    J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):215-25. PubMed ID: 22537358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
    Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
    CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children].
    Pan XX; Ma HW; Wan B; Dai XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):471-4. PubMed ID: 18706164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.
    Kim BN; Kim JW; Hong SB; Cho SC; Shin MS; Yoo HJ
    Behav Brain Funct; 2010 Oct; 6():57. PubMed ID: 20929549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the DAT1 gene and the effects of methylphenidate administration in adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
    Inci Kenar AN; Ünal GA; Güler H; Albuz B; Kıroğlu Y; Erdal ME; Herken H
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1373-8. PubMed ID: 27097961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive dysfunction in medication-naïve children with ADHD: A multi-modal fNIRS and EEG study.
    Kaga Y; Ueda R; Tanaka M; Kita Y; Suzuki K; Okumura Y; Egashira Y; Shirakawa Y; Mitsuhashi S; Kitamura Y; Nakagawa E; Yamashita Y; Inagaki M
    Brain Dev; 2020 Sep; 42(8):555-563. PubMed ID: 32532641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
    Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.